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SuicidePsychiatric disorders including anxiety, psychosis, and aggressive behaviors are frequently diagnosed in patients
with epilepsy. In this communication, we report a patients with mesial temporal lobe sclerosis with interictal
affective-somatoform (dysphoric) disorders who was never treated for psychiatric manifestations, and who
deliberately took a massive dose of phenytoin and phenobarbitone with a motive of suicide, resulting in severe
combined toxicity. Such unfortunate incidences may be prevented, and quality of life can be improved with
early diagnosis, through the selection of the right antiepileptic drugs, reasonable psychiatric consultation, and
appropriate biological and psychological treatments.
© 2013 . Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Mental disorders are very common in epilepsy. Studies have
estimated that up to 50% of patients with epilepsy develop psychiatric
disorders, the most common being depression, anxiety, and psychotic
disturbances [1]. These psychiatric disturbances can be classiﬁed
according to how they relate in time to seizure occurrence, i.e., ictal,
periictal (preictal/prodromal, postictal), or interictal. Mood and
behavioral changes can occur as a direct manifestation of the seizures,
including anxiety, depression, and hallucinations. During the interictal
period, cognitive dysfunction, psychosis, depression, anxiety disorders
(like panic disorder, generalized anxiety, agoraphobia, social phobia,
and obsessive–compulsive disorder), and dysphoric disorder have
been described [2]. Improved seizure control has been associated with
the emergence of psychiatric symptoms. Landolt introduced the term
‘forced normalization’ which refers to a dramatic reduction inerms of the Creative Commons
which permits non-commercial
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or, sometimes, behavioral/mood disturbances [3].
Mesial temporal lobe sclerosis (MTS) contributes to a signiﬁcantly
compromised quality of life for many patients [4]. The suicide rates in
people with epilepsy are ﬁve times higher than the expected rate in
the general population. However, among patients with temporal lobe
epilepsy, the suicide rate can be 25 times higher [5]. Previously, cases
having temporal lobe epilepsy with psychosis and behavioral changes
have been reported [6]. Here, we are reporting the case of a young
male who was suffering from complex partial seizure with secondary
generalization and psychiatric comorbidity. His seizures were un-
controlled despite long-term treatment, and he was never treated
for psychiatric manifestations.2. Case report
Presented here is a case of a twenty-six-year-old young male who
was brought to the emergency room in a state of unconsciousness
following by massive drug intake. He was diagnosed with complex
partial seizures with secondary generalization 14 years earlier and
was on antiepileptic treatment with 300-mg/day phenytoin sodium
and 60-mg/day phenobarbitone. His seizures were never controlled,
and he had 5–6 episodes of complex partial seizures/month. Precipitating
his emergency room presentation, he deliberately consumed a massive
dose of antiepileptic drugs (approx. 25 tablets of phenobarbitone andle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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lowing a dispute with his relatives.
As stated by his family members, there was a signiﬁcant change in
his behavior in the form of irritability, impulsivity, obstinacy, decreased
frustration tolerance, and assertiveness. His academic performance also
deteriorated. He had poor communicationwith familymembers. Before
starting antiepileptic medication, hewas performingwell in his studies.
On physical examination, the patient was of an average build with a
poor general condition. Vital signs revealed the following: a temperature
of 99.6 °F, a pulse rate of 120 beats/min, a blood pressure of 110/
68 mm Hg, a respiratory rate of 32 breaths/min, and an SPO2 of 86%. On
systemic examination, the patient was comatose (GCS: E1V2M2) with
bilateral crepitation on chest examination. The rest of the physical
examination ﬁndings was insigniﬁcant. The patient had been resuscitat-
ed, gastric lavage was done, and blood and urine samples were taken.
He was put on a ventilator and given supportive and symptomatic treat-
ment. Relevant blood parameters were also monitored. His serum drug
concentrations were measured by immunoassay and were 36 μg/ml for
phenytoin and 105.67 μg/ml for phenobarbitone. With meticulous
symptomatic management, the drug level came down to 22.40 μg/ml
for phenytoin and 52 μg/ml for phenobarbitone on the 9th day.
Gradually, his symptoms resolved, and on the 8th day, there was
complete recovery. The patient was subjected to EEG and brain MRI.
Brain MRI revealed right mesial temporal sclerosis, and EEG revealed
epileptiformdischarges arising from the right temporal area.His psychi-
atric evaluation revealed interictal affective-somatoform (dysphoric)
disorder, but no further suicidal ideations/intention were elicited. The
patient was put on 600-mg/day oxcarbazepine which was gradually
built up to 1200 mg/day, while for the psychiatric symptoms, 10-mg/day
olanzapine and 50-mg/day sertraline were started. In the follow-up
period of six months, he had three complex partial seizures, but he
had a marked improvement in depressive mood, impulsivity, and
suicidality.
3. Discussion
The complex relationship between temporal lobe epilepsy (TLE) and
psychiatric disorders (PDs) has been amatter of interest, and important
studies have emphasized this association. It is already known that psy-
chiatric comorbidity compromises a patient's quality of life [7–9]. About
6% of patients with epilepsy in general appear to suffer from a PD. This
number rises to 10–20% in populations with TLE or refractory epilepsy
[7]. Among the mood disorders, depression is the most common (24–
74%) followed by anxiety disorders (10–25%), psychoses (2–7%), and
personality disorders (1–2%). Risk factors associated with PD in TLE
are clinical refractoriness, MTS, and bitemporal lesions [8,10]. Patients
with TLE are at an increased risk of PD compared with those with
extra-TLE or primarily generalized epilepsies presumably because of
the limbic system's involvement in the regulation of emotions and be-
havior. Some studies, however, did not ﬁnd such differences [11–13].
In our case, the patient presented with TLE associated with intermittent
affective-somatoform symptoms including irritability, depressive
moods, suicidality, insomnia, atypical pains, anxiety, phobic fears, and
cognitive decline.
This young man was on prolonged unsupervised, antiepileptic
medication, and the serum level of the drugs had never beenmonitored before this unfortunate incidence. Therefore, the possi-
bility of deleterious effects of drugs (phenytoin) could not be ruled
out. Depression and suicidal tendency may be explained because of
the deterioration in cognitive performance, which may have exacer-
bated certain psychological sequelae affecting not only his vocation-
al domains but also his interpersonal and social domains. Primarily,
the decreased academic performance produced anxiety which
served to enhance performance-driven activity. The underdiagnosis
and undertreatment of depression highlighted by this study are not
new in literature, but this report signiﬁes that it is still persisting
despite numerous publications from specialists on this topic. He
was treated with antipsychotic drugs, and with treatment, there
was dramatic improvement in his depressed mood, impulsivity,
and suicidality. Other modalities of treatment for depression include
psychological interventions such as counseling, psychotherapy, or
cognitive/behavior therapy.
The prevalence of the disease in rural areas is twice that of the urban
areas. The problems faced by health-care professionals in managing
epilepsy in hugely populated rural, underserved, remote areas of India
are lack of diagnostic facilities (51.9%), treatment noncompliance
(28.2%), nonavailability of new AEDs (17.3%), lack of educational ser-
vices (17.3%), inadequate training (40.4%), nonavailability of epilepsy
surgery (17.3%), and lack of treatment insight for psychiatric comorbid-
ity [14].
With periodic clinical and psychiatric evaluation and early treatment
of psychiatric manifestations, such unfortunate incidences can be
avoided. Early recognition and management of psychiatric disorders
in patients with epilepsy is extremely important because it improves
quality of life, decreases suicidal intent, and aids in better seizure
control.
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